Total Funding
76
48
Total FundingGrant raised
Growth Score
-12 pts
Heat Score
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
36919
Biotechnology company developing pharmaceutical therapies for nerve regeneration in the central nervous system.
- Travis Stiles: Founder, President and Chief Executive Officer
- Shawn Gahr: Co-Founder, COO & CFO
About the Company
Novoron Bioscience develops new therapeutic approaches to address neurological damage or disease in the central nervous system (CNS). Our novel LRP-focused science enables hope for treatment of conditions for which no current therapies exist. We’re advancing multiple biological therapeutics that treat pathologies of the CNS, including tauopathies
(Alzheimer’s, CTE, TBI, etc.), acute spinal cord injury (orphan drug indication), and demyelinating conditions (multiple sclerosis, NMO, etc.).
Indigenous Founded
